The Most Common Cognitive Biases In Life Sciences M&A

These common examples of narrow thinking can prevent decision-makers from coming up with more than one solution to a particular problem.

The base rate is a prediction based on prior data and probabilities, absent of information specific to a particular case. In transactions, the base rate is the likelihood that a transaction will close without considering the perceived probability of the specific transaction in mind. Statistical facts seldom come into consideration in decision-making. Instead, management tends to make big decisions based on little or no information and leap from little information to big conclusions. In our experience, management will almost always neglect to take the base rate into account and, as such, decisions are exposed to additional risk to closing. Base rates should be dominant in management’s thinking and their beliefs should be constrained by the logic of probability.

A simple statistical reality is that large samples are more precise than small samples, and small samples yield extreme results...

More from Archive

More from In Vivo

Deals In Depth: June 2025

 
• By 

Five $1bn+ alliances were penned in June, and four exceeded $2bn.

Global Pharma Interest In Korea Undeterred Despite Political Roller Coaster

 
• By 

Despite recent political turmoil, outside investor and corporate interest in South Korean biopharma innovation appears robust or even increasing.

Podcast: Oxolife’s Agnés Arbat, Winner Of The European Prize For Women Innovators

 
• By 

Agnès Arbat, CEO of Oxolife and winner of the EU Women Innovators Prize, joins In Vivo to discuss OXO-001, a novel non-hormonal treatment aimed at improving embryo implantation in IVF. She shares insights from her biotech journey and the future of fertility innovation.